{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:00:36Z","timestamp":1793448036842,"version":"4.5.0"},"reference-count":108,"publisher":"American Medical Association (AMA)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,10,17]]},"abstract":"\n Importance<\/jats:title>\n \n Overt hyperthyroidism, defined as\n suppressed thyrotropin<\/jats:italic>\n (previously thyroid-stimulating hormone) and high concentration of triiodothyronine (T\n 3<\/jats:sub>\n ) and\/or free thyroxine (FT\n 4<\/jats:sub>\n ), affects approximately 0.2% to 1.4% of people worldwide. Subclinical hyperthyroidism, defined as low concentrations of thyrotropin and normal concentrations of T\n 3<\/jats:sub>\n and FT\n 4<\/jats:sub>\n , affects approximately 0.7% to 1.4% of people worldwide. Untreated hyperthyroidism can cause cardiac arrhythmias, heart failure, osteoporosis, and adverse pregnancy outcomes. It may lead to unintentional weight loss and is associated with increased mortality.\n <\/jats:p>\n <\/jats:sec>\n \n Observations<\/jats:title>\n The most common cause of hyperthyroidism is Graves disease, with a global prevalence of 2% in women and 0.5% in men. Other causes of hyperthyroidism and thyrotoxicosis include toxic nodules and the thyrotoxic phase of thyroiditis. Common symptoms of thyrotoxicosis include anxiety, insomnia, palpitations, unintentional weight loss, diarrhea, and heat intolerance. Patients with Graves disease may have a diffusely enlarged thyroid gland, stare, or exophthalmos on examination. Patients with toxic nodules (ie, in which thyroid nodules develop autonomous function) may have symptoms from local compression of structures in the neck by the thyroid gland, such as dysphagia, orthopnea, or voice changes. Etiology can typically be established based on clinical presentation, thyroid function tests, and thyrotropin-receptor antibody status. Thyroid scintigraphy is recommended if thyroid nodules are present or the etiology is unclear. Thyrotoxicosis from thyroiditis may be observed if symptomatic or treated with supportive care. Treatment options for overt hyperthyroidism from autonomous thyroid nodules or Graves disease include antithyroid drugs, radioactive iodine ablation, and surgery. Treatment for subclinical hyperthyroidism is recommended for patients at highest risk of osteoporosis and cardiovascular disease, such as those older than 65 years or with persistent serum thyrotropin level less than 0.1 mIU\/L.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Hyperthyroidism affects 2.5% of adults worldwide and is associated with osteoporosis, heart disease, and increased mortality. First-line treatments are antithyroid drugs, thyroid surgery, and radioactive iodine treatment. Treatment choices should be individualized and patient centered.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2023.19052","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T11:03:39Z","timestamp":1697540619000},"page":"1472","source":"Crossref","is-referenced-by-count":297,"title":["Hyperthyroidism"],"prefix":"10.1001","volume":"330","author":[{"given":"Sun Y.","family":"Lee","sequence":"first","affiliation":[{"name":"Section of Endocrinology, Diabetes, Nutrition, and Weight Management, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth N.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes, Nutrition, and Weight Management, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"jrv230018r1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism.","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"jrv230018r2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3803\/EnM.2020.35.1.7","article-title":"Update on thyroid hormone levels and thyroid dysfunction in the Korean population based on data from the Korea National Health and Nutrition Examination Survey VI (2013 to 2015).","volume":"35","author":"Chung","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"10","key":"jrv230018r3","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"jrv230018r4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease.","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"jrv230018r5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/cen.2013.78.issue-5","article-title":"Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005.","volume":"78","author":"Nystr\u00f6m","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"jrv230018r6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/joim.1991.229.issue-5","article-title":"High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs high incidence of Graves\u2019 disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland.","volume":"229","author":"Laurberg","year":"1991","journal-title":"J Intern Med"},{"issue":"6","key":"jrv230018r7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/thy.2006.16.573","article-title":"Prevalence of postpartum thyroid dysfunction: a quantitative review.","volume":"16","author":"Nicholson","year":"2006","journal-title":"Thyroid"},{"issue":"23","key":"jrv230018r8","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.2174\/0929867329666220831145651","article-title":"Prevalence of amiodarone induced hypothyroidism and hyperthyroidism in patients with heart diseases: a systematic review and meta-analysis.","volume":"30","author":"Rahimi-Bashar","year":"2023","journal-title":"Curr Med Chem"},{"issue":"3","key":"jrv230018r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101660","article-title":"Immune checkpoint inhibitor-related thyroid dysfunction.","volume":"36","author":"Iwama","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"jrv230018r10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.886930","article-title":"Immune related adverse events of the thyroid\u2014a narrative review.","volume":"13","author":"Muir","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"jrv230018r11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in newly diagnosed Graves\u2019 disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression.","volume":"44","author":"Ippolito","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"jrv230018r12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1530\/eje.1.02210","article-title":"The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives.","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"25","key":"jrv230018r13","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMcp1709318","article-title":"Subclinical hyperthyroidism.","volume":"378","author":"Biondi","year":"2018","journal-title":"N Engl J Med"},{"key":"jrv230018r14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.725829","article-title":"Thyroid dysfunction and sleep disorders.","volume":"12","author":"Green","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"jrv230018r15","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2022.2145","article-title":"Thyroid dysfunction on the heart: clinical effects, prognostic impact and management strategies.","volume":"92","author":"Mattesi","year":"2022","journal-title":"Monaldi Arch Chest Dis"},{"issue":"8","key":"jrv230018r16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40618-016-0452-6","article-title":"Consequences of hyperthyroidism in male and female fertility: pathophysiology and current management.","volume":"39","author":"Mintziori","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"jrv230018r17","first-page":"83","article-title":"Hyperthyroidism in the elderly, I: clinical manifestations.","volume":"23","author":"Dumitriu","year":"1985","journal-title":"Endocrinologie"},{"issue":"2","key":"jrv230018r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101742","article-title":"COVID-induced thyroid autoimmunity.","volume":"37","author":"Brancatella","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"jrv230018r19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12020-022-03247-w","article-title":"Clinical, biochemical features and functional outcome of patients with SARS-CoV-2\u2013related subacute thyroiditis: a review.","volume":"79","author":"Viola","year":"2023","journal-title":"Endocrine"},{"issue":"1","key":"jrv230018r20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12902-023-01387-2","article-title":"Graves\u2019 disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature.","volume":"23","author":"Takedani","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"jrv230018r21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/cen.v98.5","article-title":"Increased incidence of Graves\u2019 disease during the SARS-CoV2 pandemic.","volume":"98","author":"Barajas Galindo","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"jrv230018r22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","article-title":"Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update.","volume":"37","author":"Bartalena","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"jrv230018r23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.1989.00390030032006","article-title":"Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients.","volume":"149","author":"de los Santos","year":"1989","journal-title":"Arch Intern Med"},{"key":"jrv230018r24","doi-asserted-by":"publisher","first-page":"m41","DOI":"10.1136\/bmj.m41","article-title":"Thyroid disease assessment and management: summary of NICE guidance.","volume":"368","author":"Vasileiou","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"jrv230018r25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.23736\/S1824-4785.21.03344-6","article-title":"The role of laboratory medicine in the diagnosis of the hyperthyroidism.","volume":"65","author":"D\u2019Aurizio","year":"2021","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"11","key":"jrv230018r26","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2741\/4687","article-title":"Functional diagnostics for thyrotropin hormone receptor autoantibodies: bioassays prevail over binding assays.","volume":"23","author":"Lytton","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"jrv230018r27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13317-010-0014-4","article-title":"Accuracy of receptor-based methods for detection of thyrotropin-receptor autoantibodies: a new automated third-generation immunoassay shows higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism.","volume":"1","author":"Tozzoli","year":"2010","journal-title":"Auto Immun Highlights"},{"issue":"5","key":"jrv230018r28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1210\/er.2018-00119","article-title":"Interferences with thyroid function immunoassays: clinical implications and detection algorithm.","volume":"39","author":"Favresse","year":"2018","journal-title":"Endocr Rev"},{"issue":"2","key":"jrv230018r29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/cen.v92.2","article-title":"Diagnostic testing for Graves\u2019 or non-Graves\u2019 hyperthyroidism: a comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.","volume":"92","author":"Scappaticcio","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"jrv230018r30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/thy.2019.0132","article-title":"Patterns of use, efficacy, and safety of treatment options for patients with Graves\u2019 disease: a nationwide population-based study.","volume":"30","author":"Brito","year":"2020","journal-title":"Thyroid"},{"issue":"11","key":"jrv230018r31","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/thy.2019.0085","article-title":"The long-term outcome of treatment for Graves\u2019 hyperthyroidism.","volume":"29","author":"Sj\u00f6lin","year":"2019","journal-title":"Thyroid"},{"issue":"9","key":"jrv230018r32","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1210\/jc.2013-1954","article-title":"Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis.","volume":"98","author":"Sundaresh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"jrv230018r33","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1111\/bcp.v87.10","article-title":"Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.","volume":"87","author":"Morales","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"jrv230018r34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa544","article-title":"Methimazole treatment and risk of acute pancreatitis: a population-based cohort study.","volume":"105","author":"Pecere","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"jrv230018r35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1089\/thy.2014.0603","article-title":"Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem?","volume":"25","author":"Balavoine","year":"2015","journal-title":"Thyroid"},{"issue":"8","key":"jrv230018r36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.eprac.2022.05.001","article-title":"Predictors of hypothyroidism following empirical dose radioiodine in toxic thyroid nodules: real-life experience.","volume":"28","author":"Demir","year":"2022","journal-title":"Endocr Pract"},{"issue":"3","key":"jrv230018r37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/cen.2005.62.issue-3","article-title":"Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years\u2019 retrospective study.","volume":"62","author":"Ceccarelli","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"jrv230018r38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/SLA.0000000000001688","article-title":"Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes?","volume":"265","author":"Adam","year":"2017","journal-title":"Ann Surg"},{"issue":"4","key":"jrv230018r39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.surg.2009.06.026","article-title":"Thyroid hormone replacement after thyroid lobectomy.","volume":"146","author":"Stoll","year":"2009","journal-title":"Surgery"},{"issue":"4","key":"jrv230018r40","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/lary.v132.4","article-title":"Radiofrequency ablation and autonomous functioning thyroid nodules: review of the current literature.","volume":"132","author":"Muhammad","year":"2022","journal-title":"Laryngoscope"},{"issue":"3","key":"jrv230018r41","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-23-0010","article-title":"Patient needs and care: moves toward person-centered care for Graves\u2019 disease in Sweden.","volume":"12","author":"Lindo","year":"2023","journal-title":"Eur Thyroid J"},{"key":"jrv230018r42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1026998","article-title":"Acute effect of propranolol on resting energy expenditure in hyperthyroid patients.","volume":"13","author":"Senn","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"jrv230018r43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1089\/thy.2015.0277","article-title":"Development and pilot testing of an encounter tool for shared decision making about the treatment of Graves\u2019 disease.","volume":"25","author":"Brito","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"jrv230018r44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1530\/EJE-16-0527","article-title":"Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves\u2019 disease.","volume":"175","author":"Donovan","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"jrv230018r45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.surg.2022.06.044","article-title":"Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves\u2019 disease.","volume":"173","author":"Ma","year":"2023","journal-title":"Surgery"},{"key":"jrv230018r46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/CEOR.S350984","article-title":"Cost-effectiveness analysis of antithyroid drug (propylthiouracil) compared to radioactive iodine for the treatment of Graves\u2019 disease in Ethiopia.","volume":"14","author":"Mengistu","year":"2022","journal-title":"Clinicoecon Outcomes Res"},{"issue":"12","key":"jrv230018r47","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease.","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"jrv230018r48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.560157","article-title":"Effect of addition of thyroxine in the treatment of Graves\u2019 disease: a systematic review.","volume":"11","author":"Li","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"jrv230018r49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"jrv230018r50","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1210\/jc.2015-3644","article-title":"Predicting the risk of recurrence before the start of antithyroid drug therapy in patients with Graves\u2019 hyperthyroidism.","volume":"101","author":"Vos","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"jrv230018r51","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1089\/thy.2019.0180","article-title":"Increased remission rates after long-term methimazole therapy in patients with Graves\u2019 disease: results of a randomized clinical trial.","volume":"29","author":"Azizi","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"jrv230018r52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/thy.2006.16.295","article-title":"Serum thyrotropin receptor antibodies concentrations in patients with Graves\u2019 disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and\/or thyroid response modify during the observation period.","volume":"16","author":"Carella","year":"2006","journal-title":"Thyroid"},{"issue":"1","key":"jrv230018r53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12020-021-02725-x","article-title":"The longer the antithyroid drug is used, the lower the relapse rate in Graves\u2019 disease: a retrospective multicenter cohort study in Korea.","volume":"74","author":"Park","year":"2021","journal-title":"Endocrine"},{"issue":"4","key":"jrv230018r54","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.clinthera.2020.01.022","article-title":"Risk factors for the relapse of Graves\u2019 disease treated with antithyroid drugs: a systematic review and meta-analysis.","volume":"42","author":"Shi","year":"2020","journal-title":"Clin Ther"},{"issue":"12","key":"jrv230018r55","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves\u2019 disease patients following radioiodine or prolonged low dose of methimazole treatment.","volume":"25","author":"Villagelin","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"jrv230018r56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12902-020-00670-w","article-title":"Control of Graves\u2019 hyperthyroidism with very long-term methimazole treatment: a clinical trial.","volume":"21","author":"Azizi","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"jrv230018r57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eprac.2020.10.019","article-title":"Desensitization to methimazole.","volume":"27","author":"Mazhari","year":"2021","journal-title":"Endocr Pract"},{"issue":"1","key":"jrv230018r58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40268-017-0172-1","article-title":"Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management.","volume":"17","author":"Vicente","year":"2017","journal-title":"Drugs R D"},{"issue":"2","key":"jrv230018r59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0002-9610(05)80258-2","article-title":"Validity of the clinical alert on breast cancer.","volume":"159","author":"Spratt","year":"1990","journal-title":"Am J Surg"},{"issue":"2","key":"jrv230018r61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4158\/EP-2019-0221","article-title":"Side effects of PTU and MMI in the treatment of hyperthyroidism: a systematic review and meta-analysis.","volume":"26","author":"Yu","year":"2020","journal-title":"Endocr Pract"},{"issue":"6","key":"jrv230018r62","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1089\/thy.2020.0715","article-title":"Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis.","volume":"31","author":"Scappaticcio","year":"2021","journal-title":"Thyroid"},{"issue":"11","key":"jrv230018r63","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1089\/thy.2019.0589","article-title":"Association between thionamides and acute pancreatitis: a case-control study.","volume":"30","author":"Guo","year":"2020","journal-title":"Thyroid"},{"issue":"9","key":"jrv230018r64","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/MNM.0000000000000705","article-title":"Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.","volume":"38","author":"Vija Racaru","year":"2017","journal-title":"Nucl Med Commun"},{"issue":"2","key":"jrv230018r65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.amjsurg.2021.03.068","article-title":"Predictive factors of radioiodine therapy failure in Graves\u2019 disease: a meta-analysis.","volume":"223","author":"Shalaby","year":"2022","journal-title":"Am J Surg"},{"issue":"12","key":"jrv230018r66","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1097\/MNM.0000000000000384","article-title":"Methimazole discontinuation before radioiodine therapy in patients with Graves\u2019 disease.","volume":"36","author":"Zakavi","year":"2015","journal-title":"Nucl Med Commun"},{"issue":"4","key":"jrv230018r67","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy.","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"jrv230018r68","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.25072","article-title":"Cancer risk after radioactive iodine treatment for hyperthyroidism: a systematic review and meta-analysis.","volume":"4","author":"Shim","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"jrv230018r69","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/cen.2013.79.issue-5","article-title":"Total thyroidectomy vs bilateral subtotal thyroidectomy in patients with Graves\u2019 diseases: a meta-analysis of randomized clinical trials.","volume":"79","author":"Guo","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"jrv230018r70","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/SLA.0000000000003580","article-title":"The American Association of Endocrine surgeons guidelines for the definitive surgical management of thyroid disease in adults.","volume":"271","author":"Patel","year":"2020","journal-title":"Ann Surg"},{"issue":"6","key":"jrv230018r71","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/cen.v96.6","article-title":"Revisiting the role of surgery in the treatment of Graves\u2019 disease.","volume":"96","author":"Cohen","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"jrv230018r72","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/0194599819829052","article-title":"Effects of preoperative iodine administration on thyroidectomy for hyperthyroidism: a systematic review and meta-analysis.","volume":"160","author":"Tsai","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"jrv230018r73","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bjs.9384","article-title":"Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia.","volume":"101","author":"Edafe","year":"2014","journal-title":"Br J Surg"},{"issue":"4","key":"jrv230018r74","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000508484","article-title":"2020 European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules.","volume":"9","author":"Papini","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"6","key":"jrv230018r75","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/endrev\/bnaa022","article-title":"New Therapeutic horizons for Graves\u2019 hyperthyroidism.","volume":"41","author":"Lane","year":"2020","journal-title":"Endocr Rev"},{"issue":"2","key":"jrv230018r76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2265.2010.03908.x","article-title":"Subclinical thyrotoxicosis in an outpatient population\u2014predictors of outcome.","volume":"74","author":"Schouten","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"jrv230018r77","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1210\/jc.2010-2693","article-title":"The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism.","volume":"96","author":"Vadiveloo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"jrv230018r78","article-title":"Subclinical hyperthyroidism and the risk of developing cardiovascular disease\u2014a systematic review.","volume":"67","author":"Smedegaard","year":"2020","journal-title":"Dan Med J"},{"issue":"10","key":"jrv230018r79","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"issue":"3","key":"jrv230018r80","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action.","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol Rev"},{"issue":"12","key":"jrv230018r81","first-page":"e4809","article-title":"Thyrotropin, hyperthyroidism, and bone mass.","volume":"106","author":"Kim","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"jrv230018r82","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.2015.5161","article-title":"Subclinical thyroid dysfunction and fracture risk: a meta-analysis.","volume":"313","author":"Blum","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"jrv230018r83","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-2265.1994.tb02571.x","article-title":"Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism.","volume":"41","author":"Mudde","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"jrv230018r84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2265.1998.00427.x","article-title":"Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women.","volume":"48","author":"Faber","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"jrv230018r85","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/thy.2020.0433","article-title":"Treatment of subclinical hyperthyroidism in the elderly: comparison of radioiodine and long-term methimazole treatment.","volume":"31","author":"Azizi","year":"2021","journal-title":"Thyroid"},{"issue":"1","key":"jrv230018r86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7326\/M14-1456","article-title":"Screening and treatment of thyroid dysfunction: an evidence review for the US Preventive Services Task Force.","volume":"162","author":"Rugge","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"jrv230018r87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000438750","article-title":"The 2015 European Thyroid Association Guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism.","volume":"4","author":"Biondi","year":"2015","journal-title":"Eur Thyroid J"},{"issue":"3","key":"jrv230018r88","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41574-021-00604-z","article-title":"Assessment and treatment of thyroid disorders in pregnancy and the postpartum period.","volume":"18","author":"Lee","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"jrv230018r89","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00404-016-4219-2","article-title":"The effects of gestational transient thyrotoxicosis on the perinatal outcomes: a case-control study.","volume":"295","author":"Kinomoto-Kondo","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"jrv230018r90","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1097\/AOG.0000000000003893","article-title":"Thyroid disease in pregnancy: ACOG practice bulletin, number 223.","volume":"135","author":"Thyroid Disease in Pregnancy","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"3","key":"jrv230018r91","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"jrv230018r92","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.800257","article-title":"Effect of hyperthyroidism control during pregnancy on maternal and fetal outcome: a systematic review and meta-analysis.","volume":"13","author":"Alves Junior","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"jrv230018r93","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/cen.v96.6","article-title":"Antithyroid drug therapy in pregnancy and risk of congenital anomalies: systematic review and meta-analysis.","volume":"96","author":"Agrawal","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"jrv230018r94","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/01.rlu.0000242600.23386.1a","article-title":"Timing and potential role of diagnostic I-123 scintigraphy in assessing radioiodine breast uptake before ablation in postpartum women with thyroid cancer: a case series.","volume":"31","author":"Brzozowska","year":"2006","journal-title":"Clin Nucl Med"},{"issue":"1","key":"jrv230018r95","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/thy.2018.0275","article-title":"National trends in incidence, mortality, and clinical outcomes of patients hospitalized for thyrotoxicosis with and without thyroid storm in the United States, 2004-2013.","volume":"29","author":"Galindo","year":"2019","journal-title":"Thyroid"},{"issue":"6","key":"jrv230018r96","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.bja.2021.06.043","article-title":"Risk of perioperative thyroid storm in hyperthyroid patients: a systematic review.","volume":"127","author":"de Mul","year":"2021","journal-title":"Br J Anaesth"},{"issue":"1","key":"jrv230018r97","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/CCM.0000000000004078","article-title":"Thyroid storm in the ICU: a retrospective multicenter study.","volume":"48","author":"Bourcier","year":"2020","journal-title":"Crit Care Med"},{"issue":"2","key":"jrv230018r98","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis: thyroid storm.","volume":"22","author":"Burch","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"jrv230018r99","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1507\/endocrj.EJ16-0336","article-title":"2016 Guidelines for the management of thyroid storm from the Japan Thyroid Association and Japan Endocrine Society (First edition).","volume":"63","author":"Satoh","year":"2016","journal-title":"Endocr J"},{"issue":"4","key":"jrv230018r100","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8655","article-title":"Comparison of propylthiouracil vs methimazole for thyroid storm in critically ill patients.","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"jrv230018r101","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/jca.v36.5","article-title":"Therapeutic plasmapheresis for the treatment of thyrotoxicosis: a retrospective multi-center study.","volume":"36","author":"Builes-Monta\u00f1o","year":"2021","journal-title":"J Clin Apher"},{"issue":"4","key":"jrv230018r102","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3803\/EnM.2020.728","article-title":"The association of overt and subclinical hyperthyroidism with the risk of cardiovascular events and cardiovascular mortality: meta-analysis and systematic review of cohort studies.","volume":"35","author":"Sohn","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"jrv230018r103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-16-0576","article-title":"Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study.","volume":"176","author":"Dekkers","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"jrv230018r104","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1210\/jc.2017-00166","article-title":"Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum TSH.","volume":"102","author":"Lillevang-Johansen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"jrv230018r105","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S2213-8587(19)30059-2","article-title":"Primary therapy of Graves\u2019 disease and cardiovascular morbidity and mortality: a linked-record cohort study.","volume":"7","author":"Okosieme","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"jrv230018r106","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jss.2022.10.043","article-title":"Cardiovascular health by Graves\u2019 disease management modality\u2014surgery versus radioactive iodine versus antithyroid medications: a network meta-analysis.","volume":"283","author":"Issa","year":"2023","journal-title":"J Surg Res"},{"issue":"3","key":"jrv230018r107","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/bjs.10665","article-title":"All-cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism.","volume":"105","author":"Giesecke","year":"2018","journal-title":"Br J Surg"},{"issue":"7","key":"jrv230018r108","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1089\/thy.2017.0029","article-title":"Increased cardiovascular mortality and morbidity in patients treated for toxic nodular goiter compared to Graves\u2019 disease and nontoxic goiter.","volume":"27","author":"Giesecke","year":"2017","journal-title":"Thyroid"},{"key":"jrv230018r60","unstructured":"FDA drug safety communication: new boxed warning on severe liver injury with propylthiouracil. April 21, 2020. Accessed July 15, 2023. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fda-drug-safety-communication-new-boxed-warning-severe-liver-injury-propylthiouracil"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2810692\/jama_lee_2023_rv_230018_1697145024.77113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T11:03:47Z","timestamp":1697540627000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2810692"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":108,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,10,17]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.19052","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,17]]}}}